TCIM
AKCA

TIAA CREF Investment Management’s Akcea Therapeutics Inc AKCA Stock Holding History

TIAA CREF Investment Management’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$818K Sell
28,868
-188
-0.6% -$5.48K ﹤0.01% 2402
2018
Q4 		$876K Buy
29,056
+1,965
+7% +$55.1K ﹤0.01% 2332
2018
Q3 		$949K Sell
27,091
-5,562
-17% -$168K ﹤0.01% 2445
2018
Q2 		$774K Sell
32,653
-16,155
-33% -$386K ﹤0.01% 2599
2018
Q1 		$1.25M Buy
48,808
+1,858
+4% +$40K ﹤0.01% 2324
2017
Q4 		$815K Sell
46,950
-19,189
-29% -$376K ﹤0.01% 2563
2017
Q3 		$1.83M Buy
+66,139
New +$1.22M ﹤0.01% 2228

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

TIAA CREF Investment Management's AKCA Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Akcea Therapeutics Inc (AKCA) stake by 0.65% in Q1 2019, selling an estimated $5.48K and leaving 28,868 shares worth $818K. The position accounts for ﹤0.01% of the portfolio, ranked #2402.

TIAA CREF Investment Management first reported a position in AKCA in Q3 2017 and has held it in 7 quarters since. The position peaked at $1.83M in Q3 2017. 74 funds tracked by Wall St. Rank hold AKCA as of Q1 2019.

  • TIAA CREF Investment Management held 28,868 shares of Akcea Therapeutics Inc worth $818K as of Q1 2019.
  • TIAA CREF Investment Management sold 188 Akcea Therapeutics Inc shares in Q1 2019, an estimated $5.48K.
  • Akcea Therapeutics Inc made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2402 holding.
  • TIAA CREF Investment Management first reported a position in Akcea Therapeutics Inc in Q3 2017 and has held it in 7 quarters since.
  • TIAA CREF Investment Management's Akcea Therapeutics Inc position peaked at $1.83M in Q3 2017.
  • 74 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.